Related references
Note: Only part of the references are listed.Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer
Dominika E. Butler et al.
ONCOTARGET (2017)
A novel genetic- and cell-based tool for assessing the efficacy and toxicity of anticancer drugs in vitro
Lan Kluwe et al.
BIOMEDICAL PAPERS-OLOMOUC (2016)
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells
Jennifer Varin et al.
ONCOTARGET (2016)
Preclinical Assessment of the Anticancer Drug Response of Plexiform Neurofibroma Tissue Using Primary Cultures
Wei Jiang et al.
JOURNAL OF CLINICAL NEUROLOGY (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
Florian Ewald et al.
JOURNAL OF CANCER (2015)
Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth
Aparna Kaul et al.
NEURO-ONCOLOGY (2015)
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Rosa Nguyen et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
J. A. McCubrey et al.
LEUKEMIA (2014)
Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus
Slawomir Antoszczyk et al.
NEURO-ONCOLOGY (2014)
Nilotinib Is More Potent than Imatinib for Treating Plexiform Neurofibroma In Vitro and In Vivo
Jiang Wei et al.
PLOS ONE (2014)
MEK inhibitor effective against proliferation in breast cancer cell
Yan Zhou et al.
TUMOR BIOLOGY (2014)
Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
Makoto Endo et al.
CLINICAL CANCER RESEARCH (2013)
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
Florian Ewald et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Walter J. Jessen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Relevance of MPNST cell lines as models for NF1 associated-tumors
Eric Pasmant et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
Eric P. Rahrmann et al.
NATURE GENETICS (2013)
Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS
David E. Reuss et al.
PLOS ONE (2013)
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Nicole Grabinski et al.
MOLECULAR CANCER (2012)
Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells
Nicole Grabinski et al.
CELLULAR SIGNALLING (2011)
A Distinct Subset of Glioma Cell Lines with Stem Cell-like Properties Reflects the Transcriptional Phenotype of Glioblastomas and Overexpresses CXCR4 as Therapeutic Target
Alexander Schulte et al.
GLIA (2011)
Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors
Melanie Spyra et al.
PLOS ONE (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta et al.
CANCER RESEARCH (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome
Changye Zou et al.
ANNALS OF SURGERY (2009)
Rapamycin inhibits mTORC1, but not completely
Carson C. Thoreen et al.
AUTOPHAGY (2009)
Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor
Changye Y. Zou et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Clinical phenotype and genetics of neurofibromatosis type 1
H. Kehrer-Sawatzki et al.
MEDIZINISCHE GENETIK (2009)
Current Status of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
Brigitte C. Widemann
CURRENT ONCOLOGY REPORTS (2009)
TORC1 is essential for NF1-associated malignancies
Cory M. Johannessen et al.
CURRENT BIOLOGY (2008)
Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations
Stephen R. Grobmyer et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Victor-F. Mautner et al.
NEURO-ONCOLOGY (2008)
Malignant Peripheral Nerve Sheath Tumors
Gaurav Gupta et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2008)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Large-scale molecular comparison Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues
SJ Miller et al.
CANCER RESEARCH (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group
M Carli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Association between benign and malignant peripheral nerve sheath tumors in NF1
T Tucker et al.
NEUROLOGY (2005)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients
S Frahm et al.
NEUROBIOLOGY OF DISEASE (2004)
Share Paper
